Clinical trial
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
NCT00216346 · PATH, Other · Completed
Key facts
| NCT number | NCT00216346 |
|---|---|
| Title | Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis |
| Official title | A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis |
| Lead sponsor | PATH, Other |
| Collaborators | World Health Organization |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Visceral Leishmaniasis |
| Intervention type | Drug |
| Interventions | Paromomycin sulfate, Amphotericin B |
| Enrollment | 667 |
| Start date | Jun 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 3, 2014 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: